Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide adjunctive therapy in pediatric epilepsy syndromes with generalized seizures
2012-001446-18Phase 2Completed
- Sponsor
- UCB
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lacosamide in Genetic generalized epilepsy (GGE) and epilepsy, sponsored by UCB. Primary endpoint: Change in count of generalized spike-wave discharges. Started Sep 2013; status: completed.
02
Drugs
lacosamide
03
Conditions
Genetic generalized epilepsy (GGE)epilepsy
Beyond the preview
Go deeper on 2012-001446-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001446-18.